SuperworthArtelo Biosciences shares outstanding ARTL
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 301.3K
- On a year earlier
- +1319.9%
- more shares
Artelo Biosciences had 301.3K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1319.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 74.5K | +272% |
| FY2024 | 20K | +100% |
| FY2021 | 10K | +431% |
| FY2020 | 1.9K | +53% |
| FY2019 | 1.2K | +370% |
| FY2018 | 262 | −53% |
| FY2017 | 556 | +41% |
| FY2016 | 393 | +5% |
| FY2015 | 375 | +22% |
| FY2014 | 309 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 301.3K | +1320% | |
| Q1 FY26 | 82.1K | +291% | |
| Q4 FY25 | 74.5K | +272% | |
| Q3 FY25 | 29.1K | +46% | |
| Q2 FY25 | 21.2K | +7% | |
| Q1 FY25 | 21K | +6% | |
| Q4 FY24 | 20K | n/a | |
| Q3 FY24 | 19.9K | +9% | |
| Q2 FY24 | 19.9K | n/a | |
| Q1 FY24 | 19.7K | n/a | |
| Q3 FY23 | 18.2K | n/a | |
| Q3 FY21 | 12.5K | +778% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Artelo Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.